NCT05889546 Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer
| NCT ID | NCT05889546 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Indiana University |
| Condition | Small Cell Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2022-08-31 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2022-08-31 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is pilot study to establish a rapid autopsy program in Small Cell Lung Cancer (SCLC) at the Indiana University Simon Comprehensive Cancer Center and outline the components necessary for tumor tissue collection.
Eligibility Criteria
Inclusion Criteria: 1. ≥ 18 years old at the time of informed consent 2. Written informed consent and HIPAA authorization for release of personal health information. 3. Active SCLC diagnosis.
Contact & Investigator
Shadia I. Jalal, MD
PRINCIPAL INVESTIGATOR
Indiana University
Frequently Asked Questions
Who can join the NCT05889546 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Small Cell Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05889546 currently recruiting?
Yes, NCT05889546 is actively recruiting participants. Contact the research team at gabkline@iu.edu for enrollment information.
Where is the NCT05889546 trial being conducted?
This trial is being conducted at Indianapolis, United States, Indianapolis, United States, Indianapolis, United States.
Who is sponsoring the NCT05889546 clinical trial?
NCT05889546 is sponsored by Indiana University. The principal investigator is Shadia I. Jalal, MD at Indiana University. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.